Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

ClinicalTrials.gov ID: NCT06131372

Public ClinicalTrials.gov record NCT06131372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema 2.4 mg/2.4 mg) Once Weekly Versus Semaglutide 2.4 mg, Cagrilintide 2.4 mg and Placebo in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity

Study identification

NCT ID
NCT06131372
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
626 participants

Conditions and interventions

Interventions

  • Cagrilintide Drug
  • Placebo Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2024
Primary completion
Sep 23, 2025
Completion
Nov 5, 2025
Last update posted
Mar 31, 2026

2024 – 2025

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
25
Facility City State ZIP Site status
John Muir Physicians Network Concord California 94520
Valley Research Fresno California 93720
Desert Oasis Hlthcr Med Group Palm Springs California 91355
North America Research Institute San Dimas California 91773
NorCal Endocrinology and Internal Medicine San Ramon California 94583
Northeast Research Institute Fleming Island Florida 32003
Life Spring Research Foundation LLC Miami Florida 33130
Advent Health Translational Research Institute Orlando Florida 32804
Velocity Clin. Res Valparaiso Valparaiso Indiana 46383
Elite Research Center Flint Michigan 48532
Univ. of Nebraska Medical Center_Omaha Omaha Nebraska 68198
Albany Medical College Albany New York 12203
NYU Langone Nephrology Associates Mineola New York 11501
New York University Grossman School of Medicine New York New York 10016
Southgate Medical Group, LLP West Seneca New York 14224
Carteret Medical Group Morehead City North Carolina 28557
Eastern Nephrology Associates, PLLC New Bern North Carolina 28562
Brookview Hills Research Associates, LLC Winston-Salem North Carolina 27103
Ohio- Advanced Medical Research Maumee Ohio 43537
Heritage Valley Multispeciality Group Inc Beaver Pennsylvania 15009
Main Street Physician's Care Little River South Carolina 29566
Osvaldo A. Brusco MD Corpus Christi Texas 78414
Southwest Houston Research Ltd Houston Texas 77099
Clinical Advancement Center San Antonio Texas 78212
Clinical Investigation Specialists Inc, Kenosha Kenosha Wisconsin 53144

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06131372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2026 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06131372 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →